Daniel Marbach

14PUBLICATIONS

130CO-AUTHORS

Molecular targetsTumour immunologyNanotoxicology, health and safetyBioinformatic methods developmentCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jul 03, 2026

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

|Apr 07, 2026

A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Sep 24, 2025

Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.

Georgina V Long, Nitya Nair, Daniel Marbach

|May 19, 2025

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Wanxiang Shen, Thinh H Nguyen, Michelle M Li

|May 15, 2025

A microfluidic bone marrow chip for the safety profiling of biologics in pre-clinical drug development.

Leopold Koenig, Laurent Juglair, Thi Phuong Tao

|Jul 22, 2024

Contextual AI models for single-cell protein biology.

Michelle M Li, Yepeng Huang, Marissa Sumathipala

Pageof 3

Frequent Collaborators

Marinka Zitnik

Sven Bergmann

Michelle M Li

Byoung Chul Cho

Nitya Nair

Victor Moreno

Wanxiang Shen

Daniel Rohle

C Borel

D Hacker

Frequent Collaborators

Marinka Zitnik

Sven Bergmann

Michelle M Li

Byoung Chul Cho